In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta
Key facts
- Who runs it
- Insel Gruppe AG, University Hospital Bern
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 98 people, planned
- Started
- 14 Apr 2026
- Expected to end
- Dec 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- resuscitative endovascular occlusion of the aorta (REBOA)
- Advanced Cardiac Life Support (ACLS)
- Record updated
- 21 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- patients suffering from in hospital cardiac arrest (IHCA), including patients with out of hospital cardiac arrest (OHCA) and return of spontaneous circulation (ROSC), transported to the emergency department, where they suffer a second arrest (IHCA)
- successful placement of a femoral artery introducer sheath
- any electrical cardiac activity seen in the initial rhythm analysis
- ongoing effort of resuscitation as determined by study-independent resuscitation lead
Who cannot take part
- hospital visitors suffering from cardiac arrest
- traumatic cardiac arrest
- known allergies to radiographic contrast agents
- IHCA in the operating room, on intensive care unit or in the cardiac catheter laboratory
- (presumed) age under 18 years
- asystole seen in the initial rhythm analysis
- known "do not resuscitate"-order
- known or obvious pregnancy
- known aortic pathologies that render cannulation impossible
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will test if a sustained Return of Spontaneous Circulation (ROSC) in patients with cardiac arrest is more frequent when patients receive advanced cardiac life support (ACLS) alone or when they receive ACLS plus a balloon occlusion of the thoracic aorta.
The 2 groups in the trial
- Advanced Cardiac Life Support (ACLS) aloneExisting treatment, for comparison
Advanced Cardiac Life Support (ACLS) as per the hospitals standard protocol, including advanced interventions such as extended cardio-pulmonary resuscitation (eCPR).
Treatment: Advanced Cardiac Life Support (ACLS)
- Advanced Cardiac Life Support (ACLS) plus REBOATreatment being tested
Advanced Cardiac Life Support (ACLS) as per the hospitals standard protocol, including advanced interventions such as eCPR plus resuscitative balloon occlusion of the descending thoracic aorta (REBOA).
Treatment: resuscitative endovascular occlusion of the aorta (REBOA) and Advanced Cardiac Life Support (ACLS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- CPReboa: In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta
- Publications
- Record updated
- 21 August 2026